Data / Form D filings / Immunologix, Inc.
Immunologix, Inc.: Form D filings
Immunologix, Inc., a biotechnology company in Charleston, SC, filed 3 Form D notices with the SEC between 2010 and 2011. The latest, on July 20, 2011, reports $250,948 sold of a $1.1 million offering to 7 investors.
Find out what Immunologix, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 645 MEETING STREET, SUITE 8, Charleston, SC, 29403
- Phone
- (843) 789-5904
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2008
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1488257
The full lists. Form D filings in South Carolina: 341 rows, $17.05, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 20, 2011 | New notice | $1,125,000 | $250,948 | $874,052 | 7 | Jul 15, 2011 | sec.gov |
| Aug 13, 2010 | Amendment | $1,250,000 | $1,090,168 | $159,832 | 21 | Mar 18, 2010 | sec.gov |
| Apr 1, 2010 | New notice | $1,250,000 | $197,500 | $1,052,500 | 4 | Mar 18, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard A. McGregor | Director | |
| Sam A. Tetlow | Director | |
| Douglas M. Carnes | Executive Officer, Director | |
| Mark Bartosh | Director | |
| Robert N. Kennedy | Director | |
| Ryan N. Fiorini | Executive Officer, Director | |
| Lloyd A. Pearson | Executive Officer, Director |
Every Form D from the week of Jul 18, 2011 · All recent filings in South Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Immunologix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.